Posts  / #POST-204399
REDDIT

Hims & Hers to sell Lilly's Zepbound on its telehealth platform

(Reuters) -Telehealth firm Hims & Hers Health said on Monday it plans to sell Eli Lilly's weight-loss drug Zepbound on its platform.

Shares of the company were up 8.5% in afternoon trading.

Post image